Skip to main content

Advertisement

Log in

Lactonic sophorolipid–induced apoptosis in human HepG2 cells through the Caspase-3 pathway

  • Applied microbial and cell physiology
  • Published:
Applied Microbiology and Biotechnology Aims and scope Submit manuscript

Abstract

Liver cancer, one of the most common types of cancer in the world, is the second leading cause of death for cancer patients. For liver cancer, there is an urgent need for an effective treatment with no or less toxic side effects. Lactonic sophorolipids (LSL), as a potential anticancer drug, has attracted wide attention of pharmaceutical researchers with its good biological activities. The effects of LSL and cell death inhibitors were measured by MTT test on HepG2 cells. Meanwhile, the morphology of the cells was observed under a microscope. The apoptosis rate was detected by flow cytometry, and the expression levels of enzyme activity of Caspase-3 and Caspase-9 were measured by detection kits. Meanwhile, mRNA levels of Apaf-1, Caspase-3, Bax, and Bcl-2 were measured by quantitative real-time RT-PCR; protein levels of Caspase-3, Cleaved Caspase-3, Bax, and Bcl-2 were measured by western blot. LSL can inhibit the proliferation of cells, and it is possible to induce apoptosis in cells. The HepG2 cells with LSL co-culture exhibited typical apoptotic morphology, and the expression levels of enzyme activity of Caspase-3 and Caspase-9 increased (P< 0.05). We also found that LSL increases cell apoptosis rate and regulates the expression of genes and proteins associated with apoptosis through the Caspase-3 pathway. These results indicate that LSL may be one of the potential drug candidates to inhibit the proliferation and induce apoptosis in HepG2 cells.

Key points

LSL, which is of good biological activities such as anti-bacterium, virus elimination, and inflammatory response elimination, has been firstly used to intervene in vitro to investigate its effect on HepG2 cell proliferation.

LSL can inhibit the proliferation of cells, and it is possible to induce apoptosis in HepG2 cells through the Caspase-3 pathway.

The mechanism of LSL action on HepG2 cell proliferation was firstly also discussed, which provides a certain experimental reference for the clinical treatment of liver cancer.

Graphical abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

Data availability

All data generated or analyzed during this study are included in this published article.

References

Download references

Acknowledgments

We appreciate the suggestion of manuscript revised by Associate Professor Hongfei Xing from the University of Science and Technology of China.

Funding

This study received support from the Anhui Province Postdoctoral Science Foundation (Grant No. 2017B230), the China Scholarship Council Visiting Scholar Project (Grant No. 201908340044), the key project of support program for top talents of colleges and universities of Anhui Province department of education (Grant No. gxgwfx2019027), the Natural science foundation of Anhui province of China (Grant No. 1808085MC71), and the Anhui University Natural Science Research Project (Grant No. KJ2020A0383).

Author information

Authors and Affiliations

Authors

Contributions

Xiao Wang performed the experiments and analyzed the results and the manuscript. Na Xu, Qinglin Li, and Shengqi Chen helped in performing experiments. Hui Cheng, Mo Yang, and Ting Jiang assisted in statistical analysis. Xiaojing Ma, Dengke Yin, and Jun Chu designed and supervised the study, reviewed the paper, and provided technical support. All authors had final decision of report content, interpretation of data, and the decision to submit the report for publication.

Corresponding authors

Correspondence to Jun Chu, Xiaojing Ma or Dengke Yin.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

ESM 1

(PDF 761 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, X., Xu, N., Li, Q. et al. Lactonic sophorolipid–induced apoptosis in human HepG2 cells through the Caspase-3 pathway. Appl Microbiol Biotechnol 105, 2033–2042 (2021). https://doi.org/10.1007/s00253-020-11045-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00253-020-11045-5

Keywords

Navigation